Company Information
As of 10/26/22
Country
U.S.
Headquarters
San Diego
Industry
Medical Products & Equipment
CEO
Kevin Sayer
Website
Company Type
Public
Ticker
DXCM
Revenues ($M)
$2,572
Profits ($M)
$196
Market Value ($M)
$39,152
Employees
6,300
Revenue and net income for the four quarters ended on or before April 30, 2022. Market value as of Oct. 17, 2022.
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$2,448.5
27.1%
Profits ($M)
$154.7
-68.7%
Assets ($M)
$4,863.6
-
Total Stockholder Equity ($M)
$2,251.5
-
Profit Ratios
Profit as % of Revenues
6.3%
Profits as % of Assets
3.2%
Profits as % of Stockholder Equity
6.9%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
2
EPS % Change (from 2020)
-69.4%
EPS % Change (5 year annual rate)
-
EPS % Change (10 year annual rate)
-
Total Return
Total Return to Investors (2021)
45.2%
Total Return to Investors (5 year, annualized)
55.2%
Total Return to Investors (10 year, annualized)
50%
DexCom Rank History
Historical Data
| Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
|---|---|---|---|---|
| 2021 | $1,926.730.5% | $493.6388.2% | $4,290.5 | $1,826.5 |
| 2020 |
